CMV disease and colitis in a kidney transplanted patient under pembrolizumab

Eur J Cancer. 2019 Mar:109:172-174. doi: 10.1016/j.ejca.2018.12.027. Epub 2019 Feb 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects
  • Colitis / etiology*
  • Colitis / pathology
  • Cytomegalovirus / isolation & purification
  • Cytomegalovirus Infections / etiology*
  • Cytomegalovirus Infections / pathology
  • Humans
  • Kidney Transplantation / adverse effects*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / etiology
  • Polycystic Kidney Diseases / therapy*
  • Prognosis

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab